Malmö, Sweden

Anders Svensson


 

Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Malmö, DK (2013)
  • Malmo, SE (2013 - 2015)
  • Malmö, SE (2012 - 2017)
  • Malmoe, SE (2016 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: The Innovative Contributions of Anders Svensson

Introduction

Anders Svensson is a prominent inventor based in Malmö, Sweden, known for his significant contributions to the field of biotechnology. With a total of 10 patents to his name, Svensson has made remarkable advancements in therapeutic applications, particularly in the area of coagulation and immune response.

Latest Patents

One of Svensson's latest patents is focused on procoagulant antibodies. This invention relates to multispecific procoagulant antibodies capable of binding to coagulation Factor IX (FIX) and/or its activated form, Factor IXa (FIXa), as well as Factor X (FX) and/or its activated form, Factor Xa (FXa). These antibodies promote FX activation by FIXa and are designed for treating subjects suffering from coagulopathy, such as hemophilia A. The patent also includes methods, compositions, and kits for manufacturing and using these antibodies. Another significant patent involves antibodies against human NKG2D, which provides isolated anti-human NKG2D monoclonal antibodies useful for therapeutic applications in humans. These antibodies are typically fully human or humanized to minimize the risk of immune responses when administered to patients.

Career Highlights

Throughout his career, Anders Svensson has worked with notable companies such as Novo Nordisk A/S and Innate Pharma S.A.S. His work in these organizations has contributed to the development of innovative therapeutic solutions that address critical health issues.

Collaborations

Svensson has collaborated with esteemed colleagues, including Peter Andreas Nicolai Reumert Wagtmann and Stefan Zahn. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Anders Svensson's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact therapeutic applications, showcasing the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…